Cytosorbents (CTSO) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Cytosorbents Revenue Highlights

Latest Revenue (Y)

$25.13M

Latest Revenue (Q)

$8.73M

Main Segment (Y)

Grant income

Main Geography (Y)

All other countries

Cytosorbents Revenue by Period

Cytosorbents Revenue by Year

Date	Revenue	Change
2024-12-31	$25.13M	-30.88%
2023-12-31	$36.35M	23.81%
2022-12-31	$29.36M	-26.80%
2021-12-31	$40.11M	1.66%
2020-12-31	$39.45M	73.30%
2019-12-31	$22.77M	12.41%
2018-12-31	$20.25M	51.34%
2017-12-31	$13.38M	63.07%
2016-12-31	$8.21M	102.33%
2015-12-31	$4.06M	28.96%
2014-12-31	$3.15M	282.70%
2013-12-31	$821.79K	442.17%
2012-12-31	$151.57K	320.13%
2011-12-31	$36.08K	100.00%
2010-12-31	-	100.00%
2009-12-31	-	100.00%
2008-12-31	-	100.00%
2007-12-31	-	100.00%
2006-12-31	-	-100.00%
2005-05-31	$10.00K	-

Cytosorbents generated $25.13M in revenue during NA 2024, up -30.88% compared to the previous quarter, and up 110.37% compared to the same period a year ago.

Cytosorbents Revenue by Quarter

Date	Revenue	Change
2025-03-31	$8.73M	33.79%
2024-12-31	$6.52M	-24.27%
2024-09-30	$8.61M	-2.59%
2024-06-30	$8.84M	-9.65%
2024-03-31	$9.79M	33.18%
2023-12-31	$7.35M	-5.24%
2023-09-30	$7.75M	-3.94%
2023-06-30	$8.07M	2.05%
2023-03-31	$7.91M	3.51%
2022-12-31	$7.64M	18.24%
2022-09-30	$6.46M	-11.84%
2022-06-30	$7.33M	-7.48%
2022-03-31	$7.92M	-18.29%
2021-12-31	$9.70M	8.94%
2021-09-30	$8.90M	-21.67%
2021-06-30	$11.37M	12.05%
2021-03-31	$10.14M	-12.04%
2020-12-31	$11.53M	12.54%
2020-09-30	$10.25M	7.63%
2020-06-30	$9.52M	16.72%
2020-03-31	$8.16M	23.39%
2019-12-31	$6.61M	15.40%
2019-09-30	$5.73M	-2.09%
2019-06-30	$5.85M	27.81%
2019-03-31	$4.58M	-16.34%
2018-12-31	$5.47M	7.21%
2018-09-30	$5.10M	-2.73%
2018-06-30	$5.25M	18.34%
2018-03-31	$4.43M	3.19%
2017-12-31	$4.30M	24.57%
2017-09-30	$3.45M	13.41%
2017-06-30	$3.04M	17.14%
2017-03-31	$2.60M	-0.64%
2016-12-31	$2.61M	21.92%
2016-09-30	$2.14M	15.68%
2016-06-30	$1.85M	15.98%
2016-03-31	$1.60M	6.81%
2015-12-31	$1.50M	39.58%
2015-09-30	$1.07M	36.62%
2015-06-30	$784.28K	11.33%
2015-03-31	$704.49K	-19.36%
2014-12-31	$873.65K	-15.53%
2014-09-30	$1.03M	55.36%
2014-06-30	$665.73K	16.61%
2014-03-31	$570.91K	81.73%
2013-12-31	$314.16K	54.33%
2013-09-30	$203.56K	59.07%
2013-06-30	$127.97K	-27.33%
2013-03-31	$176.10K	-130.00%
2012-12-31	$-587.04K	-196.98%
2012-09-30	$605.35K	1732.05%
2012-06-30	$33.04K	95.60%
2012-03-31	$16.89K	-53.18%
2011-12-31	$36.08K	100.00%
2011-09-30	-	100.00%
2011-06-30	-	100.00%
2011-03-31	-	100.00%
2010-12-31	-	100.00%
2010-09-30	-	100.00%
2010-06-30	-	100.00%
2010-03-31	-	100.00%
2009-12-31	-	100.00%
2009-09-30	-	100.00%
2009-06-30	-	100.00%
2009-03-31	-	100.00%
2008-12-31	-	100.00%
2008-09-30	-	100.00%
2008-06-30	-	100.00%
2008-03-31	-	100.00%
2007-12-31	-	-

Cytosorbents generated $8.73M in revenue during Q1 2025, up 33.79% compared to the previous quarter, and up 118.77% compared to the same period a year ago.

Cytosorbents Revenue Breakdown

Cytosorbents Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Other sales	$69.69K	$787.20K	-	-	-
Grant income	$5.26M	-	-	-	-
Cyto Sorb Sales	-	-	$40.00M	$39.34M	$22.55M
Other Sales	-	-	$111.87K	$110.40K	$220.10K

Cytosorbents's latest annual revenue breakdown by segment (product or service), as of Dec 23: Grant income (98.69%), and Other sales (1.31%).

Quarterly Revenue by Product

Product/Service	Sep 24	Jun 24	Mar 24	Dec 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
Other sales	$26.52K	$11.40K	$24.73K	$59.33K	$6.58K	$3.77K	$245.51K	$191.47K	$292.63K	-	-	-	-	-	-	-	-	-	-	-
Grant income	$777.59K	$1.05M	$796.77K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cyto Sorb Sales	-	-	-	-	-	-	-	-	$7.04M	$7.87M	$9.59M	$8.90M	$11.36M	$10.14M	$11.49M	$10.25M	$9.45M	$8.16M	$6.54M	$5.65M
Other product sales	-	-	-	-	-	-	-	-	-	$57.59K	-	-	-	-	-	-	-	-	-	-
Other Sales	-	-	-	-	-	-	-	-	-	-	$106.29K	$797.00	$4.78K	$41.40K	-	$69.00K	-	$73.30K	$80.00K	-

Cytosorbents's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Grant income (96.70%), and Other sales (3.30%).

Cytosorbents Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
All other countries	$22.39M	$18.05M	$15.82M	$17.41M	-
Germany	$13.05M	$12.96M	-	-	-
United States	$150.61K	$5.26M	$968.95K	$1.69M	-
All Other Countries	-	-	-	-	$17.85M
D	-	-	-	-	-
U	-	-	-	-	$1.34M

Cytosorbents's latest annual revenue breakdown by geography, as of Dec 24: All other countries (62.91%), Germany (36.66%), and United States (0.42%).

Quarterly Revenue by Country

Country	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20
All other countries	$6.20M	$5.87M	$5.55M	$5.41M	$6.02M	$5.41M	$8.59M	$4.90M	$4.57M	$3.77M	$4.04M	$3.93M	$3.92M	$4.66M	-	-	-	-	-	-
United States	$61.00K	$62.61K	-	$777.59K	$1.05M	$796.77K	$2.38M	$1.35M	$1.54M	$1.75M	$200.47K	$310.63K	$212.34K	$446.74K	$577.45K	-	-	-	-	-
Germany	$3.35M	$2.80M	$3.55M	$3.18M	$2.78M	$3.54M	$6.46M	$3.17M	$3.34M	$2.49M	$2.98M	$3.78M	$5.33M	$3.66M	-	-	-	-	-	-
All Other Countries	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$4.88M	$3.94M	$5.20M	$5.17M	$4.25M
D	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$6.12M	$5.90M	$5.99M	-	-
U	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$362.03K	$455.49K	$344.20K	$261.50K	$274.57K

Cytosorbents's latest quarterly revenue breakdown by geography, as of Jun 25: All other countries (64.48%), Germany (34.89%), and United States (0.63%).

Cytosorbents Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
AXGN	AxoGen	$187.34M	$56.66M
CTMX	CytomX Therapeutics	$138.10M	$50.92M
SRDX	Surmodics	$126.08M	$28.09M
NAGE	Niagen Bioscience	$99.60M	$29.13M
BLFS	BioLife Solutions	$82.25M	$23.94M
NPCE	NeuroPace	$79.91M	$23.52M
CVRX	CVRx	$51.29M	$13.59M
DCTH	Delcath Systems	$31.02M	-
CTSO	Cytosorbents	$25.13M	$8.73M

CTSO Revenue FAQ

What is Cytosorbents’s yearly revenue?

Cytosorbents's yearly revenue for 2024 was $25.13M, representing a decrease of -30.88% compared to 2023. The company's yearly revenue for 2023 was $36.35M, representing an increase of 23.81% compared to 2022. CTSO's yearly revenue for 2022 was $29.36M, representing a decrease of -26.80% compared to 2021.

What is Cytosorbents’s quarterly revenue?

Cytosorbents's quarterly revenue for Q1 2025 was $8.73M, a 33.79% increase from the previous quarter (Q4 2024), and a -10.82% decrease year-over-year (Q1 2024). The company's quarterly revenue for Q4 2024 was $6.52M, a -24.27% decrease from the previous quarter (Q3 2024), and a -11.23% decrease year-over-year (Q4 2023). CTSO's quarterly revenue for Q3 2024 was $8.61M, a -2.59% decrease from the previous quarter (Q2 2024), and a 11.08% increase year-over-year (Q3 2023).

What is Cytosorbents’s revenue growth rate?

Cytosorbents's revenue growth rate for the last 3 years (2022-2024) was -14.42%, and for the last 5 years (2020-2024) was -36.31%.

What are Cytosorbents’s revenue streams?

Cytosorbents's revenue streams in c 23 are Other sales, and Grant income. Other sales generated $69.68K in revenue, accounting 1.31% of the company's total revenue, down -91.15% year-over-year. Grant income generated $5.26M in revenue, accounting 98.69% of the company's total revenue

What is Cytosorbents’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Cytosorbents was Grant income. This segment made a revenue of $5.26M, representing 98.69% of the company's total revenue.